Daily Round Up: 7/14/14

by: InsiderInsights


Tables of the top insider purchases and sales filed with the SEC on Monday, July 14, 2014, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are further given for selected companies.

I cannot repeat enough that dollar value is only one metric to assess the significance of an insider transaction. InsiderInsights calculates Insider Filer Statistics in real time, and formulates Insider Company Ratings based on numerous behavioral factors, so our clients can separate real investment intelligence from time-wasting noise.

On Today's Tables:

Insider trades were only rated Significant at one firm:

  • Nature's Sunshine (NASDAQ:NATR).

Insider trades were rated Nearly Significant at:

  • Regeneron Pharmaceuticals (NASDAQ:REGN);
  • Invesco Van Kampen Muni Trust (NYSE:VKQ), and;

Insider trades were considered Insignificant at:

  • Ultragenyx Pharmaceutical (NASDAQ:RARE);
  • Rex American Resources (NYSE:REX);
  • Invesco VK Tr for Investment Grade Munis (NYSE:VGM);
  • Targa Resources (NYSE:TRGP), and;
  • Constellation Energy Partners (NYSEMKT:CEP).

There is a Conflicted Insider Signal at:

  • Bluebird Bio (NASDAQ:BLUE).

For more on how to profit from our Daily Round Up tables and analyze insider data, see references below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Sanofi BO Regeneron Pharm REGN AB $54,439,072
2 Dammeyer R F DIR Invesco Tr Inv Gr Muni VGM B $248,887
3 Dammeyer R F DIR Invesco Municipal Trust VKQ B $248,636
4 Wynnefld SmCap Val BO Nature's Sunshine NATR B $122,033
5 Maraganore John DIR Bluebird Bio BLUE B $99,994
6 Hoffman David F O LM BW Gl Inc Opp Fd BWG B $72,819
7 Scott Sterling C BO Growlife PHOT JB* $67,614
8 Langan Eric Scott CEO,DIR,BO Ricks Cabaret Intl RICK B $37,985
9 Rlj Spac Acquisition BO Rlj Entertainment RLJE B $22,628
10 Gibbs John D BO Athena Silver AHNR B $14,918

Source: | Key to Insider Title and Trans Type Codes:
B=Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 TPG Group BO Ultragenyx Pharm RARE JS* $18,379,632
2 Rose Stuart A CEO,DIR,BO Rex American REX S $3,911,755
3 Perkins Joe Bob CEO,DIR Targa Resources TRGP AS $3,446,614
4 Gans Stephen BO Digital Ally DGLY S $2,861,163
5 Donaker Geoffrey COO,DIR YELP YELP AS $1,723,367
6 Kestenbaum Alan CB,DIR,BO Gl Sp Metals GSM S $1,013,568
7 Edelman & Guill BO Constellation Energy CEP S $750,240
8 Leeson Lorie VP,TR Greenbrier Companies GBX S $660,000
9 Romano Stephen A DIR Us Ecology ECOL AS $490,800
10 Drako Dean M DIR,BO Barracuda Netw CUDA AS $422,380 | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

An important note from Jonathan Moreland, founder of

In a victory for common sense, it's been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders".

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations.

At, our clients find new investment ideas every day using more intricate insider screens to determine where they should focus their subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be profitable indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

So use these daily articles as the initial research tools they are meant to be, and click the links in the tables to analyze a company's or insider's full insider history. Also feel free to email us with any questions on our proprietary insider data, filer statistics, and company ratings.

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.